{"id":31075,"date":"2022-11-17T11:31:26","date_gmt":"2022-11-17T10:31:26","guid":{"rendered":"https:\/\/cancerprev.ch\/?page_id=31075"},"modified":"2026-09-13T21:39:59","modified_gmt":"2026-09-13T19:39:59","slug":"research-3","status":"publish","type":"page","link":"https:\/\/cancerprev.com\/fr\/research-3\/","title":{"rendered":"Research"},"content":{"rendered":"<p class=\"has-medium-font-size\">CancerPrev brings together&nbsp;<strong>researchers, clinicians and patient advocates<\/strong>&nbsp;to develop new approaches to cancer prevention, connecting mechanistic research with clinical experience and the perspectives of people directly affected by cancer.<\/p>\n\n\n\n<div class=\"wp-block-media-text alignwide is-stacked-on-mobile\" style=\"grid-template-columns:35% auto\"><figure class=\"wp-block-media-text__media\"><img loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"1024\" src=\"https:\/\/cancerprev.com\/wp-content\/uploads\/2022\/12\/siqwyinliju-1024x1024.jpg\" alt=\"\" class=\"wp-image-31163 size-full\" srcset=\"https:\/\/cancerprev.com\/wp-content\/uploads\/2022\/12\/siqwyinliju-1024x1024.jpg 1024w, https:\/\/cancerprev.com\/wp-content\/uploads\/2022\/12\/siqwyinliju-300x300.jpg 300w, https:\/\/cancerprev.com\/wp-content\/uploads\/2022\/12\/siqwyinliju-150x150.jpg 150w, https:\/\/cancerprev.com\/wp-content\/uploads\/2022\/12\/siqwyinliju-768x768.jpg 768w, https:\/\/cancerprev.com\/wp-content\/uploads\/2022\/12\/siqwyinliju-100x100.jpg 100w, https:\/\/cancerprev.com\/wp-content\/uploads\/2022\/12\/siqwyinliju.jpg 1200w\" sizes=\"auto, (max-width: 706px) 89vw, (max-width: 767px) 82vw, 740px\" \/><\/figure><div class=\"wp-block-media-text__content\">\n<h1 class=\"wp-block-heading has-medium-font-size\"><a class=\"ek-link\" href=\"https:\/\/cancerprev.com\/fr\/Dotto\/\"><strong>FIELD CANCERIZATION AND TISSUE REMODELING<\/strong><\/a><\/h1>\n\n\n\n<p class=\"has-small-font-size\"><strong>Field cancerization<\/strong>\u00a0is a condition of major clinical significance, closely linked to\u00a0<strong>aging and the progressive acquisition of genetic and epigenetic changes<\/strong>, in which tissues are transformed into cancer-prone states that generate multiple and recurrent lesions. Our program investigates how\u00a0<strong>common determinants of this process across cancer and stromal cells<\/strong> interact with organismal determinants, including\u00a0<strong>sex and inherited genetic background<\/strong>. We study how cancer-prone states are sustained through\u00a0<strong>epigenetic forms of biological memory, and how this memory can be reversed<\/strong>, with the ultimate goal of therapeutically redirecting cancer-prone tissue states.<\/p>\n<\/div><\/div>\n\n\n\n<div class=\"wp-block-media-text alignwide is-stacked-on-mobile\" style=\"grid-template-columns:35% auto\"><figure class=\"wp-block-media-text__media\"><img loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"1024\" src=\"https:\/\/cancerprev.com\/wp-content\/uploads\/2022\/12\/njv6xnlpnaa-e1670402723556-1024x1024.jpg\" alt=\"person with pink band on her left hand\" class=\"wp-image-31165 size-full\" srcset=\"https:\/\/cancerprev.com\/wp-content\/uploads\/2022\/12\/njv6xnlpnaa-e1670402723556-1024x1024.jpg 1024w, https:\/\/cancerprev.com\/wp-content\/uploads\/2022\/12\/njv6xnlpnaa-e1670402723556-300x300.jpg 300w, https:\/\/cancerprev.com\/wp-content\/uploads\/2022\/12\/njv6xnlpnaa-e1670402723556-150x150.jpg 150w, https:\/\/cancerprev.com\/wp-content\/uploads\/2022\/12\/njv6xnlpnaa-e1670402723556-768x768.jpg 768w, https:\/\/cancerprev.com\/wp-content\/uploads\/2022\/12\/njv6xnlpnaa-e1670402723556-100x100.jpg 100w, https:\/\/cancerprev.com\/wp-content\/uploads\/2022\/12\/njv6xnlpnaa-e1670402723556.jpg 1064w\" sizes=\"auto, (max-width: 706px) 89vw, (max-width: 767px) 82vw, 740px\" \/><\/figure><div class=\"wp-block-media-text__content\">\n<h1 class=\"wp-block-heading has-medium-font-size\"><a class=\"ek-link\" href=\"https:\/\/www.epfl.ch\/labs\/brisken-lab\/\"><strong>LOBULAR BREAST CANCER &amp; PREVENTION<\/strong><\/a><\/h1>\n<\/div><\/div>\n\n\n\n<p class=\"editorskit-no-desktop editorskit-no-tablet editorskit-no-mobile has-small-font-size\"><\/p>\n\n\n\n<p class=\"has-small-font-size\"><strong>Invasive lobular breast cancer<\/strong>&nbsp;is a distinct and understudied form of breast cancer, strongly influenced by&nbsp;<strong>hormonal signaling and interactions with the surrounding tissue microenvironment<\/strong>. Our program investigates the mechanisms underlying the development and progression of lobular breast cancer, using physiologically relevant experimental models to uncover&nbsp;<strong>hormonal and stromal determinants of disease<\/strong>. By identifying vulnerabilities that distinguish lobular from other forms of breast cancer, we aim to develop new approaches for&nbsp;<strong>risk reduction, prevention and targeted intervention<\/strong>.<\/p>\n\n\n\n<p><\/p>","protected":false},"excerpt":{"rendered":"<p>CancerPrev brings together&nbsp;researchers, clinicians and patient advocates&nbsp;to develop new approaches to cancer prevention, connecting mechanistic research with clinical experience and the perspectives of people directly affected by cancer. FIELD CANCERIZATION AND TISSUE REMODELING Field cancerization\u00a0is a condition of major clinical significance, closely linked to\u00a0aging and the progressive acquisition of genetic and epigenetic changes, in which &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/cancerprev.com\/fr\/research-3\/\" class=\"more-link\">Continuer la lecture<span class=\"screen-reader-text\"> de &laquo;&nbsp;Research&nbsp;&raquo;<\/span><\/a><\/p>","protected":false},"author":8,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_editorskit_title_hidden":false,"_editorskit_reading_time":1,"_editorskit_is_block_options_detached":false,"_editorskit_block_options_position":"{}","footnotes":""},"class_list":["post-31075","page","type-page","status-publish","hentry"],"featured_image_src":null,"_links":{"self":[{"href":"https:\/\/cancerprev.com\/fr\/wp-json\/wp\/v2\/pages\/31075","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cancerprev.com\/fr\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/cancerprev.com\/fr\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/cancerprev.com\/fr\/wp-json\/wp\/v2\/users\/8"}],"replies":[{"embeddable":true,"href":"https:\/\/cancerprev.com\/fr\/wp-json\/wp\/v2\/comments?post=31075"}],"version-history":[{"count":28,"href":"https:\/\/cancerprev.com\/fr\/wp-json\/wp\/v2\/pages\/31075\/revisions"}],"predecessor-version":[{"id":32765,"href":"https:\/\/cancerprev.com\/fr\/wp-json\/wp\/v2\/pages\/31075\/revisions\/32765"}],"wp:attachment":[{"href":"https:\/\/cancerprev.com\/fr\/wp-json\/wp\/v2\/media?parent=31075"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}